News

Video

ASCRS 2025: Eva Kim, MD, says patient comfort is paramount when using implantable collamer lenses

For patients with high myopia, an implantable ICL offers certain advantages over LASIK or other traditional refractive surgeries, Dr. Kim said.

This year, the American Society of Cataract and Refractive Surgery (ASCRS) holds its annual meeting in Los Angeles, California. On the first day of the meeting, the Eye Care Network spoke with Eva Kim, MD, an ophthalmologist and refractive specialist from Denver, Colorado. She spoke about the EVO implantable collamer lens (ICL), a reversible intervention for patients with high myopia. According to Dr. Kim, these ICLs have a number of qualities which make them appealing to younger patients with high myopia, including removability and a less-invasive implantation procedure. There's also no need for a preoperative laser peripheral iridotomy—a factor which wins over many patients, she said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.